Catharus ustulatus isolate bCatUst1 chromosome 17, bCatUst1.pri.v2, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Passeriformes; Turdidae; Catharus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM020352.1.\nAssembly name: bCatUst1.pri.v2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2020/12/22. The original whole-genome shotgun project has the\naccession WNMQ00000000.2.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 06-AUG-2020\nAssembly Method :: FALCON v. DX 1.9.0; FALCON-Unzip v.\n 6.0.0.47841; purge_dups github v.\n purge_haplotig (bitbucket v1.0.3+\n 1.Nov.2018); Scaff10x v. 2; Bionano Solve\n v. 3.2.1_04122018; Salsa2 HiC v. 2.2;\n Arrow polishing and gap filling v.\n Smrtlink_6.0.0.47841; Longranger Align v.\n 2.2.2; freebayes v. 1.3.1; gEVAL manual\n curation v. 2020-08-06; VGP assembly\n pipeline v. 1.5\nAssembly Name :: bCatUst1.pri.v2\nDiploid :: Principal pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 60.58x\nSequencing Technology :: PacBio Sequel I CLR; Illumina NovaSeq;\n Arima Genomics Hi-C; Bionano Genomics DLS\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Catharus ustulatus Annotation\n Release 101\nAnnotation Version :: 101\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
nuclear receptor coactivator 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
nuclear receptor coactivator 3, transcript variant X1
COORDINATES: polyA evidence [ECO:0006239]
nuclear receptor coactivator 3, transcript variant X2
nuclear receptor coactivator 3 isoform X1
nuclear receptor coactivator 3 isoform X2
nuclear receptor coactivator 3 isoform X3
extracellular sulfatase Sulf-2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 6 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
extracellular sulfatase Sulf-2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 6 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
extracellular sulfatase Sulf-2 isoform X3
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1, transcript variant X1
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1, transcript variant X3
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1, transcript variant X2
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1, transcript variant X4
phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein isoform X1
phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein isoform X3
phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein isoform X2
phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein isoform X4
ADP ribosylation factor guanine nucleotide exchange factor 2, transcript variant X1
brefeldin A-inhibited guanine nucleotide-exchange protein 2 isoform X1
ADP ribosylation factor guanine nucleotide exchange factor 2, transcript variant X2
brefeldin A-inhibited guanine nucleotide-exchange protein 2 isoform X2
staufen double-stranded RNA binding protein 1, transcript variant X1
staufen double-stranded RNA binding protein 1, transcript variant X2
staufen double-stranded RNA binding protein 1, transcript variant X3
double-stranded RNA-binding protein Staufen homolog 1 isoform X1
double-stranded RNA-binding protein Staufen homolog 1 isoform X2
double-stranded RNA-binding protein Staufen homolog 1 isoform X3
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00581
somatomedin-B and thrombospondin type-1 domain-containing protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
potassium voltage-gated channel subfamily B member 1, transcript variant X2
potassium voltage-gated channel subfamily B member 1, transcript variant X1
potassium voltage-gated channel subfamily B member 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
spermatogenesis associated 2, transcript variant X2
spermatogenesis associated 2, transcript variant X1
spermatogenesis-associated protein 2 isoform X1
spermatogenesis-associated protein 2 isoform X2
snail family transcriptional repressor 1
ubiquitin-conjugating enzyme E2 variant 1, transcript variant X2
ubiquitin-conjugating enzyme E2 variant 1, transcript variant X1
ubiquitin-conjugating enzyme E2 variant 1 isoform X2
ubiquitin-conjugating enzyme E2 variant 1 isoform X1
protein tyrosine phosphatase non-receptor type 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
tyrosine-protein phosphatase non-receptor type 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
par-6 family cell polarity regulator beta
activity dependent neuroprotector homeobox, transcript variant X5
activity dependent neuroprotector homeobox, transcript variant X2
activity dependent neuroprotector homeobox, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 ESTs, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
activity dependent neuroprotector homeobox, transcript variant X4
activity dependent neuroprotector homeobox, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 ESTs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
activity dependent neuroprotector homeobox, transcript variant X3
activity-dependent neuroprotector homeobox protein isoform X1
activity-dependent neuroprotector homeobox protein isoform X2
dolichyl-phosphate mannosyltransferase subunit 1, catalytic
dolichol-phosphate mannosyltransferase subunit 1
adenylyltransferase and sulfurtransferase MOCS3
potassium voltage-gated channel modifier subfamily G member 1, transcript variant X3
potassium voltage-gated channel modifier subfamily G member 1, transcript variant X1
potassium voltage-gated channel modifier subfamily G member 1, transcript variant X2
potassium voltage-gated channel subfamily G member 1
nuclear factor of activated T-cells, cytoplasmic 2-like, transcript variant X3
nuclear factor of activated T-cells, cytoplasmic 2-like, transcript variant X1
nuclear factor of activated T-cells, cytoplasmic 2-like, transcript variant X2
nuclear factor of activated T-cells, cytoplasmic 2-like isoform X3
nuclear factor of activated T-cells, cytoplasmic 2-like isoform X1
nuclear factor of activated T-cells, cytoplasmic 2-like isoform X2
probable phospholipid-transporting ATPase IIA
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
nuclear factor of activated T-cells, cytoplasmic 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 52 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC117004463, transcript variant X2
uncharacterized LOC117004463, transcript variant X1
spalt like transcription factor 4, transcript variant X1
spalt like transcription factor 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
teashirt zinc finger homeobox 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 ESTs, 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
teashirt zinc finger homeobox 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 ESTs, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
teashirt zinc finger homeobox 2, transcript variant X1
brain enriched myelin associated protein 1
uncharacterized LOC117004542, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC117004542, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial isoform X1
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial isoform X2
docking protein 5, transcript variant X3
docking protein 5, transcript variant X1
docking protein 5, transcript variant X2
docking protein 5, transcript variant X5
docking protein 5, transcript variant X4
docking protein 5, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
family with sequence similarity 210 member B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
cleavage stimulation factor subunit 1, transcript variant X2
cleavage stimulation factor subunit 1, transcript variant X1
cleavage stimulation factor subunit 1 isoform X1
cleavage stimulation factor subunit 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 7-like, transcript variant X2
beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 7-like, transcript variant X1
beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 7-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 30% coverage of the annotated genomic feature by RNAseq alignments
SPO11 initiator of meiotic double stranded breaks
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 10% coverage of the annotated genomic feature by RNAseq alignments
ribonucleic acid export 1, transcript variant X1
ribonucleic acid export 1, transcript variant X2
RNA binding motif protein 38, transcript variant X1
RNA binding motif protein 38, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 71% coverage of the annotated genomic feature by RNAseq alignments
phosphoenolpyruvate carboxykinase, cytosolic [GTP]
prostate transmembrane protein, androgen induced 1, transcript variant X3
prostate transmembrane protein, androgen induced 1, transcript variant X2
prostate transmembrane protein, androgen induced 1, transcript variant X1
uncharacterized protein C20orf85 homolog
serine/threonine-protein phosphatase 4 regulatory subunit 1-like, transcript variant X2
serine/threonine-protein phosphatase 4 regulatory subunit 1-like, transcript variant X1
serine/threonine-protein phosphatase 4 regulatory subunit 1-like isoform X2
serine/threonine-protein phosphatase 4 regulatory subunit 1-like isoform X1
vesicle-associated membrane protein-associated protein B/C
GNAS complex locus, transcript variant X1
guanine nucleotide-binding protein G(s) subunit alpha isoform X1
GNAS complex locus, transcript variant X2
guanine nucleotide-binding protein G(s) subunit alpha isoform X2
negative elongation factor complex member C/D, transcript variant X2
negative elongation factor complex member C/D, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
negative elongation factor C/D isoform X2
negative elongation factor C/D isoform X1
tubulin beta 1 class VI, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
tubulin beta 1 class VI, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
tubulin beta 1 class VI, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tubulin beta 1 class VI, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
tubulin beta 1 class VI, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 60 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
zinc finger protein 831, transcript variant X2
zinc finger protein 831, transcript variant X1
zinc finger protein 831, transcript variant X3
zinc finger protein 831, transcript variant X4
phosphatase and actin regulator 3, transcript variant X1
phosphatase and actin regulator 3, transcript variant X2
phosphatase and actin regulator 3 isoform X1
phosphatase and actin regulator 3 isoform X2
protein phosphatase 1 regulatory subunit 3D
family with sequence similarity 217 member B, transcript variant X1
family with sequence similarity 217 member B, transcript variant X4
family with sequence similarity 217 member B, transcript variant X2
family with sequence similarity 217 member B, transcript variant X3
family with sequence similarity 217 member B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
TATA-box binding protein associated factor 4
transcription initiation factor TFIID subunit 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
LSM family member 14B, transcript variant X4
LSM family member 14B, transcript variant X1
LSM family member 14B, transcript variant X3
LSM family member 14B, transcript variant X2
SS18L1 subunit of BAF chromatin remodeling complex
mitochondrial ribosome associated GTPase 2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: mitochondrial ribosome-associated GTPase 2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 5 bases in 4 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 5 bases in 4 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: histamine H3 receptor
oxysterol binding protein like 2, transcript variant X1
oxysterol binding protein like 2, transcript variant X2
oxysterol-binding protein-related protein 2 isoform X1
oxysterol binding protein like 2, transcript variant X3
oxysterol-binding protein-related protein 2 isoform X2
ADRM1 26S proteasome ubiquitin receptor, transcript variant X1
ADRM1 26S proteasome ubiquitin receptor, transcript variant X3
ADRM1 26S proteasome ubiquitin receptor, transcript variant X2
proteasomal ubiquitin receptor ADRM1 isoform X1
proteasomal ubiquitin receptor ADRM1 isoform X2
laminin subunit alpha 5, transcript variant X2
laminin subunit alpha 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 71% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 21 Proteins, and 41% coverage of the annotated genomic feature by RNAseq alignments
solute carrier organic anion transporter family member 4A1, transcript variant X2
solute carrier organic anion transporter family member 4A1, transcript variant X1
solute carrier organic anion transporter family member 4A1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
GID complex subunit 8 homolog, transcript variant X1
GID complex subunit 8 homolog, transcript variant X2
glucose-induced degradation protein 8 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
basic helix-loop-helix family member e23
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 ESTs, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
class E basic helix-loop-helix protein 23
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
YTH N6-methyladenosine RNA binding protein 1, transcript variant X2
YTH domain-containing family protein 1 isoform X2
YTH N6-methyladenosine RNA binding protein 1, transcript variant X1
YTH domain-containing family protein 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
baculoviral IAP repeat-containing protein 7
sodium/potassium transporting ATPase interacting 4, transcript variant X3
sodium/potassium transporting ATPase interacting 4, transcript variant X4
sodium/potassium transporting ATPase interacting 4, transcript variant X1
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 isoform X4
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 isoform X1
sodium/potassium transporting ATPase interacting 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 isoform X3
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 isoform X2
ADP ribosylation factor GTPase activating protein 1, transcript variant X1
ADP ribosylation factor GTPase activating protein 1, transcript variant X3
ADP ribosylation factor GTPase activating protein 1, transcript variant X6
ADP ribosylation factor GTPase activating protein 1, transcript variant X2
ADP ribosylation factor GTPase activating protein 1, transcript variant X5
ADP ribosylation factor GTPase activating protein 1, transcript variant X4
ADP ribosylation factor GTPase activating protein 1, transcript variant X7
ADP-ribosylation factor GTPase-activating protein 1 isoform X1
ADP-ribosylation factor GTPase-activating protein 1 isoform X3
ADP-ribosylation factor GTPase-activating protein 1 isoform X6
ADP-ribosylation factor GTPase-activating protein 1 isoform X2
ADP-ribosylation factor GTPase-activating protein 1 isoform X5
ADP-ribosylation factor GTPase-activating protein 1 isoform X4
ADP-ribosylation factor GTPase-activating protein 1 isoform X7
DEP domain-containing mTOR-interacting protein-like, transcript variant X3
DEP domain-containing mTOR-interacting protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
DEP domain-containing mTOR-interacting protein-like, transcript variant X2
DEP domain-containing mTOR-interacting protein-like isoform X2
uncharacterized protein LOC117004321 isoform X1
cholinergic receptor nicotinic alpha 4 subunit, transcript variant X1
neuronal acetylcholine receptor subunit alpha-4 isoform X1
cholinergic receptor nicotinic alpha 4 subunit, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 45 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
neuronal acetylcholine receptor subunit alpha-4 isoform X2
potassium voltage-gated channel subfamily Q member 2, transcript variant X10
potassium voltage-gated channel subfamily Q member 2, transcript variant X3
potassium voltage-gated channel subfamily Q member 2, transcript variant X6
potassium voltage-gated channel subfamily Q member 2, transcript variant X11
potassium voltage-gated channel subfamily Q member 2, transcript variant X7
potassium voltage-gated channel subfamily Q member 2, transcript variant X9
potassium voltage-gated channel subfamily Q member 2, transcript variant X5
potassium voltage-gated channel subfamily Q member 2, transcript variant X4
potassium voltage-gated channel subfamily Q member 2, transcript variant X2
potassium voltage-gated channel subfamily Q member 2, transcript variant X8
potassium voltage-gated channel subfamily Q member 2, transcript variant X1
potassium voltage-gated channel subfamily KQT member 2 isoform X10
potassium voltage-gated channel subfamily KQT member 2 isoform X3
potassium voltage-gated channel subfamily KQT member 2 isoform X6
potassium voltage-gated channel subfamily KQT member 2 isoform X11
potassium voltage-gated channel subfamily KQT member 2 isoform X7
potassium voltage-gated channel subfamily KQT member 2 isoform X9
potassium voltage-gated channel subfamily KQT member 2 isoform X5
potassium voltage-gated channel subfamily KQT member 2 isoform X4
potassium voltage-gated channel subfamily KQT member 2 isoform X2
potassium voltage-gated channel subfamily KQT member 2 isoform X8
potassium voltage-gated channel subfamily KQT member 2 isoform X1
eukaryotic translation elongation factor 1 alpha 2
pancreatic progenitor cell differentiation and proliferation factor, transcript variant X2
pancreatic progenitor cell differentiation and proliferation factor, transcript variant X1
pancreatic progenitor cell differentiation and proliferation factor, transcript variant X3
pancreatic progenitor cell differentiation and proliferation factor
src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 18 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2
protein-L-isoaspartate O-methyltransferase domain-containing protein 2
myelin transcription factor 1, transcript variant X2
myelin transcription factor 1, transcript variant X1
myelin transcription factor 1, transcript variant X3
myelin transcription factor 1, transcript variant X4
myelin transcription factor 1 isoform X2
myelin transcription factor 1 isoform X1
myelin transcription factor 1 isoform X3
uncharacterized LOC117004403, transcript variant X2
uncharacterized LOC117004403, transcript variant X3
uncharacterized LOC117004403, transcript variant X1
uncharacterized protein LOC117004403 isoform X2
uncharacterized protein LOC117004403 isoform X1
neuropeptides B and W receptor 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 1 EST, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
neuropeptides B and W receptor 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 1 EST, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized LOC117004207, transcript variant X2
uncharacterized LOC117004207, transcript variant X1
regulator of G protein signaling 19, transcript variant X1
regulator of G protein signaling 19, transcript variant X2
transcription elongation factor A2, transcript variant X2
transcription elongation factor A2, transcript variant X3
transcription elongation factor A protein 2 isoform X2
transcription elongation factor A protein 2 isoform X3
transcription elongation factor A2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 29 ESTs, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
transcription elongation factor A protein 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
uncharacterized protein C20orf204 homolog
sterile alpha motif domain containing 10, transcript variant X4
sterile alpha motif domain containing 10, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
sterile alpha motif domain-containing protein 10 isoform X4
sterile alpha motif domain-containing protein 10 isoform X3
sterile alpha motif domain containing 10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
sterile alpha motif domain containing 10, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
sterile alpha motif domain containing 10, transcript variant X2
sterile alpha motif domain-containing protein 10 isoform X2
sterile alpha motif domain-containing protein 10 isoform X1
sterile alpha motif domain-containing protein 10 isoform X5
zinc finger protein 512B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 17 ESTs, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
zinc finger protein 512B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
zinc finger protein 512B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 10 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
zinc finger protein 512B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 18 ESTs, 9 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
zinc finger protein 512B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 11 ESTs, 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uridine-cytidine kinase 1 like 1, transcript variant X1
uridine-cytidine kinase 1 like 1, transcript variant X2
uridine-cytidine kinase-like 1 isoform X1
uridine-cytidine kinase-like 1 isoform X2
DnaJ heat shock protein family (Hsp40) member C5
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glutamic acid (anticodon CUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
zinc finger and BTB domain containing 46, transcript variant X5
zinc finger and BTB domain containing 46, transcript variant X4
zinc finger and BTB domain containing 46, transcript variant X1
zinc finger and BTB domain containing 46, transcript variant X8
zinc finger and BTB domain containing 46, transcript variant X7
zinc finger and BTB domain containing 46, transcript variant X6
zinc finger and BTB domain containing 46, transcript variant X3
zinc finger and BTB domain containing 46, transcript variant X2
zinc finger and BTB domain-containing protein 46 isoform X1
zinc finger and BTB domain-containing protein 46 isoform X3
zinc finger and BTB domain-containing protein 46 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
zinc finger CCCH-type and G-patch domain containing
zinc finger CCCH-type with G patch domain-containing protein
ADP ribosylation factor related protein 1
ADP-ribosylation factor-related protein 1
TNF receptor superfamily member 6b, transcript variant X2
TNF receptor superfamily member 6b, transcript variant X3
TNF receptor superfamily member 6b, transcript variant X4
TNF receptor superfamily member 6b, transcript variant X5
TNF receptor superfamily member 6b, transcript variant X1
tumor necrosis factor receptor superfamily member 6B
regulator of telomere elongation helicase 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
regulator of telomere elongation helicase 1 isoform X5
regulator of telomere elongation helicase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
regulator of telomere elongation helicase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
regulator of telomere elongation helicase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
regulator of telomere elongation helicase 1, transcript variant X1
regulator of telomere elongation helicase 1 isoform X2
regulator of telomere elongation helicase 1 isoform X1
regulator of telomere elongation helicase 1 isoform X3
regulator of telomere elongation helicase 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
regulator of telomere elongation helicase 1 isoform X4
glucocorticoid modulatory element binding protein 2, transcript variant X2
glucocorticoid modulatory element binding protein 2, transcript variant X1
glucocorticoid modulatory element-binding protein 2 isoform X1
glucocorticoid modulatory element-binding protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
fibronectin type III domain containing 11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 41% coverage of the annotated genomic feature by RNAseq alignments
fibronectin type III domain-containing protein 11
tyrosine-protein phosphatase non-receptor type substrate 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
peptidyl-prolyl cis-trans isomerase FKBP1A
RAD21 cohesin complex component like 1, transcript variant X5
RAD21 cohesin complex component like 1, transcript variant X7
RAD21 cohesin complex component like 1, transcript variant X6
RAD21 cohesin complex component like 1, transcript variant X1
RAD21 cohesin complex component like 1, transcript variant X3
RAD21 cohesin complex component like 1, transcript variant X2
RAD21 cohesin complex component like 1, transcript variant X4
RAD21 cohesin complex component like 1, transcript variant X8
double-strand-break repair protein rad21-like protein 1 isoform X3
double-strand-break repair protein rad21-like protein 1 isoform X5
double-strand-break repair protein rad21-like protein 1 isoform X4
double-strand-break repair protein rad21-like protein 1 isoform X1
double-strand-break repair protein rad21-like protein 1 isoform X2
double-strand-break repair protein rad21-like protein 1 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 19 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
family with sequence similarity 110 member A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 52 member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
solute carrier family 52 member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 52 member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 52, riboflavin transporter, member 3 isoform X2
solute carrier family 52, riboflavin transporter, member 3 isoform X1
scratch family transcriptional repressor 2
casein kinase 2 alpha 1, transcript variant X1
casein kinase 2 alpha 1, transcript variant X2
TBC1 domain family member 20, transcript variant X1
TBC1 domain family member 20, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
histocompatibility minor 13, transcript variant X1
histocompatibility minor 13, transcript variant X3
histocompatibility minor 13, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 ESTs, 8 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
minor histocompatibility antigen H13 isoform X1
minor histocompatibility antigen H13 isoform X3
minor histocompatibility antigen H13 isoform X2
bactericidal permeability-increasing protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 50% coverage of the annotated genomic feature by RNAseq alignments
TPX2 microtubule nucleation factor, transcript variant X2
TPX2 microtubule nucleation factor, transcript variant X1
TPX2 microtubule nucleation factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 12% coverage of the annotated genomic feature by RNAseq alignments
myosin light chain kinase 2, skeletal/cardiac muscle
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 21 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 11 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cerebral cavernous malformations 2 protein-like
HCK proto-oncogene, Src family tyrosine kinase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 82 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
GDP-fucose protein O-fucosyltransferase 1
kinesin family member 3B, transcript variant X1
kinesin family member 3B, transcript variant X2
nucleolar protein 4 like, transcript variant X1
nucleolar protein 4 like, transcript variant X3
nucleolar protein 4 like, transcript variant X2
uncharacterized LOC117004185, transcript variant X1
uncharacterized LOC117004185, transcript variant X3
uncharacterized LOC117004185, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
microtubule associated protein RP/EB family member 1
microtubule-associated protein RP/EB family member 1
BPI fold-containing family B member 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 23% coverage of the annotated genomic feature by RNAseq alignments
BPI fold-containing family B member 3-like, transcript variant X1
BPI fold-containing family B member 3-like, transcript variant X2
BPI fold-containing family B member 3-like
CDK5 regulatory subunit associated protein 1
mitochondrial tRNA methylthiotransferase CDK5RAP1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 65% coverage of the annotated genomic feature by RNAseq alignments
bactericidal permeability increasing protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
bactericidal permeability-increasing protein
KIAA1755 ortholog, transcript variant X1
uncharacterized protein KIAA1755 homolog isoform X1
KIAA1755 ortholog, transcript variant X2
uncharacterized protein KIAA1755 homolog isoform X2
protein-glutamine gamma-glutamyltransferase 2
regulation of nuclear pre-mRNA domain containing 1B
regulation of nuclear pre-mRNA domain-containing protein 1B
TELO2 interacting protein 1, transcript variant X1
TELO2 interacting protein 1, transcript variant X2
TELO2-interacting protein 1 homolog isoform X1
TELO2-interacting protein 1 homolog isoform X2
V-set and transmembrane domain containing 2 like, transcript variant X2
V-set and transmembrane domain containing 2 like, transcript variant X1
V-set and transmembrane domain containing 2 like, transcript variant X4
V-set and transmembrane domain containing 2 like, transcript variant X3
V-set and transmembrane domain-containing protein 2-like protein isoform X2
V-set and transmembrane domain-containing protein 2-like protein isoform X1
V-set and transmembrane domain-containing protein 2-like protein isoform X4
V-set and transmembrane domain-containing protein 2-like protein isoform X3
WAP four-disulfide core domain protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 16% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 23% coverage of the annotated genomic feature by RNAseq alignments
deoxynucleotidyltransferase terminal interacting protein 1, transcript variant X1
deoxynucleotidyltransferase terminal interacting protein 1, transcript variant X2
deoxynucleotidyltransferase terminal-interacting protein 1 isoform X1
deoxynucleotidyltransferase terminal-interacting protein 1 isoform X2
ubiquitin conjugating enzyme E2 C, transcript variant X1
ubiquitin conjugating enzyme E2 C, transcript variant X2
ubiquitin-conjugating enzyme E2 C isoform X2
ubiquitin-conjugating enzyme E2 C isoform X1
regulator of G-protein signaling 9-binding protein-like
troponin C2, fast skeletal type, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
troponin C2, fast skeletal type, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger SWIM domain-containing protein 1-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 7 bases in 4 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 76% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 7 bases in 4 codons; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: zinc finger SWIM domain-containing protein 1-like
neuralized E3 ubiquitin protein ligase 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
phosphorylated CTD interacting factor 1, transcript variant X1
phosphorylated CTD interacting factor 1, transcript variant X2
mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase
putative iroquois-class homeodomain protein irx-1
LOW QUALITY PROTEIN: zinc finger protein 335
solute carrier family 12 member 5, transcript variant X3
solute carrier family 12 member 5 isoform X2
solute carrier family 12 member 5, transcript variant X1
solute carrier family 12 member 5, transcript variant X2
solute carrier family 12 member 5 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 5 isoform X1
tumor necrosis factor receptor superfamily member 5 isoform X2
solute carrier family 35 member C2, transcript variant X1
solute carrier family 35 member C2, transcript variant X2
solute carrier family 35 member C2 isoform X1
solute carrier family 35 member C2 isoform X2
engulfment and cell motility 2, transcript variant X1
engulfment and cell motility 2, transcript variant X6
engulfment and cell motility 2, transcript variant X5
engulfment and cell motility 2, transcript variant X4
engulfment and cell motility 2, transcript variant X3
engulfment and cell motility 2, transcript variant X7
engulfment and cell motility 2, transcript variant X2
engulfment and cell motility protein 2 isoform X3
engulfment and cell motility protein 2 isoform X2
engulfment and cell motility protein 2 isoform X1
small nuclear ribonucleoprotein polypeptides B and B1
small nuclear ribonucleoprotein-associated proteins B and B'
probable ATP-dependent RNA helicase DDX27
zinc finger NFX1-type containing 1, transcript variant X1
zinc finger NFX1-type containing 1, transcript variant X2
NFX1-type zinc finger-containing protein 1 isoform X1
NFX1-type zinc finger-containing protein 1 isoform X2
zinc finger NFX1-type containing 1, transcript variant X3
NFX1-type zinc finger-containing protein 1 isoform X3
protein-glutamine gamma-glutamyltransferase 6-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protein-glutamine gamma-glutamyltransferase 6-like
protein-glutamine gamma-glutamyltransferase E-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 49% coverage of the annotated genomic feature by RNAseq alignments
zinc finger MYND-type containing 8, transcript variant X2
zinc finger MYND-type containing 8, transcript variant X7
protein kinase C-binding protein 1 isoform X2
protein kinase C-binding protein 1 isoform X5
zinc finger MYND-type containing 8, transcript variant X1
zinc finger MYND-type containing 8, transcript variant X3
protein kinase C-binding protein 1 isoform X1
protein kinase C-binding protein 1 isoform X3
zinc finger MYND-type containing 8, transcript variant X4
zinc finger MYND-type containing 8, transcript variant X6
zinc finger MYND-type containing 8, transcript variant X5
protein kinase C-binding protein 1 isoform X4
EYA transcriptional coactivator and phosphatase 2, transcript variant X3
EYA transcriptional coactivator and phosphatase 2, transcript variant X4
EYA transcriptional coactivator and phosphatase 2, transcript variant X2
EYA transcriptional coactivator and phosphatase 2, transcript variant X1
EYA transcriptional coactivator and phosphatase 2, transcript variant X5
solute carrier family 2, facilitated glucose transporter member 10
osteoclast stimulatory transmembrane protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
thyrotropin-releasing hormone receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
oxidative stress responsive serine rich 1, transcript variant X1
oxidative stress responsive serine rich 1, transcript variant X2
oxidative stress-responsive serine-rich protein 1
oxidative stress-responsive serine-rich protein 1-like
ganglioside induced differentiation associated protein 1 like 1
ganglioside-induced differentiation-associated protein 1-like 1
fat storage inducing transmembrane protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 2 ESTs, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
alpha tocopherol transfer protein like, transcript variant X1
alpha tocopherol transfer protein like, transcript variant X2
cAMP-dependent protein kinase inhibitor gamma, transcript variant X4
cAMP-dependent protein kinase inhibitor gamma, transcript variant X2
cAMP-dependent protein kinase inhibitor gamma, transcript variant X3
cAMP-dependent protein kinase inhibitor gamma, transcript variant X1
cAMP-dependent protein kinase inhibitor gamma
adenosine deaminase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
adenosine deaminase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
potassium two pore domain channel subfamily K member 15
regulating synaptic membrane exocytosis 4
regulating synaptic membrane exocytosis protein 4
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta, transcript variant X1
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta, transcript variant X2
poly(A) binding protein cytoplasmic 1 like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 25% coverage of the annotated genomic feature by RNAseq alignments
translocase of outer mitochondrial membrane 34
mitochondrial import receptor subunit TOM34
serine/threonine kinase 4, transcript variant X1
serine/threonine kinase 4, transcript variant X2
serine/threonine-protein kinase 4 isoform X1
serine/threonine-protein kinase 4 isoform X2
potassium voltage-gated channel modifier subfamily S member 1, transcript variant X1
potassium voltage-gated channel modifier subfamily S member 1, transcript variant X6
potassium voltage-gated channel modifier subfamily S member 1, transcript variant X4
potassium voltage-gated channel modifier subfamily S member 1, transcript variant X3
potassium voltage-gated channel modifier subfamily S member 1, transcript variant X2
potassium voltage-gated channel modifier subfamily S member 1, transcript variant X5
potassium voltage-gated channel subfamily S member 1
recombination signal binding protein for immunoglobulin kappa J region like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 19 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
recombining binding protein suppressor of hairless-like protein
SYS1 golgi trafficking protein, transcript variant X2
SYS1 golgi trafficking protein, transcript variant X1
dysbindin domain containing 2, transcript variant X2
dysbindin domain containing 2, transcript variant X1
dysbindin domain-containing protein 2 isoform X1
dysbindin domain containing 2, transcript variant X3
dysbindin domain-containing protein 2 isoform X2
phosphatidylinositol glycan anchor biosynthesis class T
SRC proto-oncogene, non-receptor tyrosine kinase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
SRC proto-oncogene, non-receptor tyrosine kinase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 71 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
SRC proto-oncogene, non-receptor tyrosine kinase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
proto-oncogene tyrosine-protein kinase Src isoform X2
proto-oncogene tyrosine-protein kinase Src isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 isoform X2
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 48% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 82% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 58% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 80% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 74% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
zinc fingers and homeoboxes 3, transcript variant X1
zinc fingers and homeoboxes 3, transcript variant X6
zinc fingers and homeoboxes 3, transcript variant X5
zinc fingers and homeoboxes 3, transcript variant X2
zinc fingers and homeoboxes 3, transcript variant X4
zinc fingers and homeoboxes 3, transcript variant X3
zinc fingers and homeoboxes protein 3 isoform X1
zinc fingers and homeoboxes protein 3 isoform X2
phospholipase C gamma 1, transcript variant X1
phospholipase C gamma 1, transcript variant X2
phospholipase C gamma 1, transcript variant X3
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X2
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X3
probable ATP-dependent RNA helicase DHX35
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 5 bases in 3 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 5 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: probable ATP-dependent RNA helicase DHX35
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protein FAM83D-A-like
probable ATP-dependent RNA helicase DHX35, transcript variant X2
probable ATP-dependent RNA helicase DHX35, transcript variant X1
probable ATP-dependent RNA helicase DHX35 isoform X2
probable ATP-dependent RNA helicase DHX35 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 16 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
protein phosphatase 1 regulatory subunit 16B
protein phosphatase 1 regulatory inhibitor subunit 16B
Rho GTPase activating protein 40, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Rho GTPase activating protein 40, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
rho GTPase-activating protein 40 isoform X1
rho GTPase-activating protein 40 isoform X2
vesicular inhibitory amino acid transporter
serum/glucocorticoid regulated kinase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
serine/threonine-protein kinase Sgk2 isoform X1
serum/glucocorticoid regulated kinase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
serine/threonine-protein kinase Sgk2 isoform X2
intraflagellar transport protein 52 homolog
protein tyrosine phosphatase receptor type T, transcript variant X3
protein tyrosine phosphatase receptor type T, transcript variant X4
protein tyrosine phosphatase receptor type T, transcript variant X7
protein tyrosine phosphatase receptor type T, transcript variant X5
protein tyrosine phosphatase receptor type T, transcript variant X2
protein tyrosine phosphatase receptor type T, transcript variant X1
protein tyrosine phosphatase receptor type T, transcript variant X9
protein tyrosine phosphatase receptor type T, transcript variant X8
protein tyrosine phosphatase receptor type T, transcript variant X6
receptor-type tyrosine-protein phosphatase T isoform X8
receptor-type tyrosine-protein phosphatase T isoform X6
receptor-type tyrosine-protein phosphatase T isoform X3
receptor-type tyrosine-protein phosphatase T isoform X4
receptor-type tyrosine-protein phosphatase T isoform X7
receptor-type tyrosine-protein phosphatase T isoform X5
receptor-type tyrosine-protein phosphatase T isoform X2
receptor-type tyrosine-protein phosphatase T isoform X1
receptor-type tyrosine-protein phosphatase T isoform X9
suppressor of glucose, autophagy associated 1, transcript variant X3
suppressor of glucose, autophagy associated 1, transcript variant X2
suppressor of glucose, autophagy associated 1, transcript variant X1
acyl-CoA synthetase short chain family member 2, transcript variant X1
acyl-CoA synthetase short chain family member 2, transcript variant X2
acetyl-coenzyme A synthetase, cytoplasmic isoform X1
acetyl-coenzyme A synthetase, cytoplasmic isoform X2
transient receptor potential cation channel subfamily C member 4 associated protein, transcript variant X2
transient receptor potential cation channel subfamily C member 4 associated protein, transcript variant X1
short transient receptor potential channel 4-associated protein isoform X2
short transient receptor potential channel 4-associated protein isoform X1
ER degradation-enhancing alpha-mannosidase-like protein 2
TOX high mobility group box family member 2
CBFA2/RUNX1 partner transcriptional co-repressor 2, transcript variant X1
CBFA2/RUNX1 partner transcriptional co-repressor 2, transcript variant X3
CBFA2/RUNX1 partner transcriptional co-repressor 2, transcript variant X2
CBFA2/RUNX1 partner transcriptional co-repressor 2, transcript variant X4
CBFA2/RUNX1 partner transcriptional co-repressor 2, transcript variant X8
CBFA2/RUNX1 partner transcriptional co-repressor 2, transcript variant X6
CBFA2/RUNX1 partner transcriptional co-repressor 2, transcript variant X5
CBFA2/RUNX1 partner transcriptional co-repressor 2, transcript variant X7
N-terminal EF-hand calcium binding protein 3
N-terminal EF-hand calcium-binding protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 62% coverage of the annotated genomic feature by RNAseq alignments
RALY heterogeneous nuclear ribonucleoprotein, transcript variant X1
RALY heterogeneous nuclear ribonucleoprotein, transcript variant X4
RALY heterogeneous nuclear ribonucleoprotein, transcript variant X3
RALY heterogeneous nuclear ribonucleoprotein, transcript variant X2
eukaryotic translation initiation factor 2 subunit beta
eukaryotic translation initiation factor 2 subunit 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 22 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
endoplasmic reticulum-Golgi intermediate compartment protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 45% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 1% coverage of the annotated genomic feature by RNAseq alignments
reactive oxygen species modulator 1, transcript variant X1
reactive oxygen species modulator 1, transcript variant X2
RNA binding motif protein 39, transcript variant X2
RNA binding motif protein 39, transcript variant X1
RNA binding motif protein 39, transcript variant X4
RNA binding motif protein 39, transcript variant X3
transfer RNA glutamic acid (anticodon UUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
rho GTPase-activating protein 39-like, transcript variant X1
rho GTPase-activating protein 39-like isoform X1
rho GTPase-activating protein 39-like, transcript variant X2
rho GTPase-activating protein 39-like isoform X2
PHD finger protein 20, transcript variant X6
PHD finger protein 20, transcript variant X9
PHD finger protein 20, transcript variant X1
PHD finger protein 20, transcript variant X5
PHD finger protein 20, transcript variant X7
PHD finger protein 20, transcript variant X11
PHD finger protein 20, transcript variant X8
PHD finger protein 20, transcript variant X10
PHD finger protein 20, transcript variant X2
PHD finger protein 20, transcript variant X3
PHD finger protein 20, transcript variant X4
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X1
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X2
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X3
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X5
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X4
ral GTPase-activating protein subunit beta isoform X1
ral GTPase-activating protein subunit beta isoform X2
ral GTPase-activating protein subunit beta isoform X3
ral GTPase-activating protein subunit beta isoform X5
ral GTPase-activating protein subunit beta isoform X4
chromodomain helicase DNA binding protein 6, transcript variant X1
chromodomain helicase DNA binding protein 6, transcript variant X7
chromodomain helicase DNA binding protein 6, transcript variant X8
chromodomain helicase DNA binding protein 6, transcript variant X2
chromodomain helicase DNA binding protein 6, transcript variant X4
chromodomain helicase DNA binding protein 6, transcript variant X5
chromodomain helicase DNA binding protein 6, transcript variant X10
chromodomain helicase DNA binding protein 6, transcript variant X6
chromodomain helicase DNA binding protein 6, transcript variant X9
chromodomain-helicase-DNA-binding protein 6 isoform X9
chromodomain-helicase-DNA-binding protein 6 isoform X1
chromodomain-helicase-DNA-binding protein 6 isoform X7
chromodomain-helicase-DNA-binding protein 6 isoform X8
chromodomain-helicase-DNA-binding protein 6 isoform X2
chromodomain-helicase-DNA-binding protein 6 isoform X4
chromodomain-helicase-DNA-binding protein 6 isoform X5
chromodomain-helicase-DNA-binding protein 6 isoform X10
chromodomain helicase DNA binding protein 6, transcript variant X3
chromodomain-helicase-DNA-binding protein 6 isoform X3
chromodomain-helicase-DNA-binding protein 6 isoform X6
RB transcriptional corepressor like 1, transcript variant X1
RB transcriptional corepressor like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
retinoblastoma-like protein 1 isoform X1
retinoblastoma-like protein 1 isoform X2
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1, transcript variant X2
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1, transcript variant X1
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1, transcript variant X5
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1, transcript variant X3
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1, transcript variant X6
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1, transcript variant X4
deoxynucleoside triphosphate triphosphohydrolase SAMHD1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
phosphatidylinositol glycan anchor biosynthesis class U
phosphatidylinositol glycan anchor biosynthesis class U protein
tumor protein p53 inducible nuclear protein 2, transcript variant X2
tumor protein p53 inducible nuclear protein 2, transcript variant X4
tumor protein p53 inducible nuclear protein 2, transcript variant X3
tumor protein p53 inducible nuclear protein 2, transcript variant X5
tumor protein p53 inducible nuclear protein 2, transcript variant X6
tumor protein p53 inducible nuclear protein 2, transcript variant X1
tumor protein p53 inducible nuclear protein 2, transcript variant X7
tumor protein p53-inducible nuclear protein 2 isoform X1
tumor protein p53-inducible nuclear protein 2 isoform X2
nuclear receptor coactivator 6, transcript variant X2
nuclear receptor coactivator 6, transcript variant X1
nuclear receptor coactivator 6 isoform X2
nuclear receptor coactivator 6 isoform X1
nuclear receptor coactivator 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
nuclear receptor coactivator 6 isoform X3
nuclear receptor coactivator 6, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
gamma-glutamyltransferase 7, transcript variant X2
gamma-glutamyltransferase 7, transcript variant X1
myosin light chain 9, transcript variant X2
myosin light chain 9, transcript variant X1
myosin light chain 9, transcript variant X3
TGFB induced factor homeobox 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
TGFB induced factor homeobox 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
DLG associated protein 4, transcript variant X6
DLG associated protein 4, transcript variant X1
DLG associated protein 4, transcript variant X5
DLG associated protein 4, transcript variant X4
DLG associated protein 4, transcript variant X3
DLG associated protein 4, transcript variant X2
DLG associated protein 4, transcript variant X7
DLG associated protein 4, transcript variant X8
disks large-associated protein 4 isoform X4
disks large-associated protein 4 isoform X3
disks large-associated protein 4 isoform X2
disks large-associated protein 4 isoform X1
disks large-associated protein 4 isoform X5
disks large-associated protein 4 isoform X6
disks large-associated protein 4 isoform X7
erythrocyte membrane protein band 4.1 like 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: band 4.1-like protein 1
serine and arginine rich splicing factor 6
L3MBTL histone methyl-lysine binding protein 1, transcript variant X2
L3MBTL histone methyl-lysine binding protein 1, transcript variant X1
L3MBTL histone methyl-lysine binding protein 1, transcript variant X3
L3MBTL histone methyl-lysine binding protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
lethal(3)malignant brain tumor-like protein 1 isoform X1
lethal(3)malignant brain tumor-like protein 1 isoform X2
lethal(3)malignant brain tumor-like protein 1 isoform X3
immunoglobulin superfamily member 1-like, transcript variant X6
immunoglobulin superfamily member 1-like, transcript variant X5
immunoglobulin superfamily member 1-like, transcript variant X4
immunoglobulin superfamily member 1-like, transcript variant X1
immunoglobulin superfamily member 1-like, transcript variant X2
immunoglobulin superfamily member 1-like, transcript variant X3
immunoglobulin superfamily member 1-like isoform X6
uncharacterized protein LOC117004305 isoform X4
uncharacterized protein LOC117004305 isoform X1
uncharacterized protein LOC117004305 isoform X2
immunoglobulin superfamily member 1-like isoform X3
uncharacterized protein LOC117004305 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments
E3 ubiquitin-protein ligase Itchy homolog
microtubule associated protein 1 light chain 3 alpha
microtubule-associated proteins 1A/1B light chain 3A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 17 Proteins, and 10% coverage of the annotated genomic feature by RNAseq alignments
ubiquinol-cytochrome-c reductase complex assembly factor 1, transcript variant X1
ubiquinol-cytochrome-c reductase complex assembly factor 1, transcript variant X2
ubiquinol-cytochrome-c reductase complex assembly factor 1 isoform X1
ubiquinol-cytochrome-c reductase complex assembly factor 1 isoform X2
family with sequence similarity 83 member C
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC117004331, transcript variant X1
uncharacterized LOC117004331, transcript variant X2
eukaryotic translation initiation factor 6
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: zinc finger protein 239-like